Discovery of the rd12 mouse, a mouse that spontaneously developed a similar RPE65 mutation as LCA patients, has made a powerful, new, independent model available for studying LCA2 pathogenesis and progression [15]. The gene discussed is RPE65; the disease is Leber congenital amaurosis.